Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xialiqi capsule for type III prostatitis
ChiCTR2100050501Phase 4Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Sep 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Xialiqi in chronic prostatitis (CP), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Chronic Prostatitis Symptom Scale score. Started Sep 2021; status: recruiting.
02
Drugs
Xialiqi
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on ChiCTR2100050501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050501.